Leronlimab should be a very effective treatment against Multiple Myeloma. It should be less expensive and without the serious side effects of CAR-T therapy. Additionally, Leronlimab could be used, in conjunction with CAR-T therapy, to give synergistic effect and lessen adverse reactions due to inflammation from resulting increased cytokinesis.


https://www.ncbi.nlm.nih.gov/pmc/articles/PMC...1%2C105%5D.



https://www.cancer.org/cancer/managing-cancer...cell1.html